Jules Bordet Institute registers Phase 2 scalp cooling trial for ADC-related hair lossNov 16Trial updateGilead Sciencessacituzumab govitecan
FDA approves datopotamab deruxtecan-dlnk for unresectable or metastatic TNBCNov 6Regulatory decisiondatopotamab deruxtecan
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
AstraZeneca, Daiichi Sankyo, Summit to test Datroway with ivonescimab comboOct 2PartnershipAstraZenecaDaiichi Sankyo
BeyondSpring updates Plinabulin data, names new CEO, reports Q2 2026 resultsAug 14Quarterly updateBeyondSpring Pharmaceuticals Inc.
Datroway wins EU approval for first-line metastatic TNBCJul 31Regulatory decisionAstraZenecadatopotamab deruxtecan
AstraZeneca registers Phase III bladder cancer trial; joins Natera-led breast cancer studyJul 23Weekly roundup, 5 itemsAstraZenecaAZD6489
CHMP backs Datroway for first-line TNBC treatment in EUJun 29Regulatory milestoneAstraZenecadatopotamab deruxtecan